Nanjing Medlander Medical Technology Co.,Ltd. Stock

Equities

688273

CNE100005PV8

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 06:00:00 2024-06-13 pm EDT 5-day change 1st Jan Change
20.63 CNY -2.04% Intraday chart for Nanjing Medlander Medical Technology Co.,Ltd. +3.98% -38.07%
Sales 2022 377M 51.95M Sales 2023 341M 46.98M Capitalization 3.35B 462M
Net income 2022 122M 16.82M Net income 2023 89M 12.27M EV / Sales 2022 5.45 x
Net cash position 2022 1.21B 166M Net cash position 2023 1.09B 150M EV / Sales 2023 6.64 x
P/E ratio 2022
22.3 x
P/E ratio 2023
37.1 x
Employees 481
Yield 2022
3.99%
Yield 2023
1.8%
Free-Float 31.83%
More Fundamentals * Assessed data
Dynamic Chart
Medlander Medical Technology Scraps 193 Million Yuan Maidou Health Deal MT
Nanjing Medlander Medical Technology Co.,Ltd. cancelled the acquisition of 55% stake in Nanjing Maidou Health Technology Co., Ltd. from Wu Henglong, Zheng Weifeng, Nanjing Xinlan Equity Investment Partnership (Limited Partnership) and Nanjing Maichuang Enterprise Management Partnership Enterprise (Limited Partnership) CI
Nanjing Medlander Medical Technology Acquiring 55% Stake in Nanjing Maidou Health Technology MT
Nanjing Medlander Medical Technology Co.,Ltd. agreed to acquire 55% stake in Nanjing Maidou Health Technology Co., Ltd. from Wu Henglong, Zheng Weifeng, Nanjing Xinlan Equity Investment Partnership (Limited Partnership) and Nanjing Maichuang Enterprise Management Partnership Enterprise (Limited Partnership) for CNY 190 million. CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Medlander Medical Technology Buys Back Shares for 31 Million Yuan MT
Tranche Update on Nanjing Medlander Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on August 23, 2023. CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Nanjing Medlander Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on August 23, 2023. CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Nanjing Medlander Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on August 23, 2023. CI
Nanjing Medlander Medical Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Nanjing Medlander Medical Technology Co.,Ltd. announces an Equity Buyback for CNY 40 million worth of its shares. CI
Nanjing Medlander Medical Technology Co.,Ltd. authorizes a Buyback Plan. CI
Medlander Medical’s Chairman Proposes Up to 40 Million Yuan Share Buyback MT
More news
1 day-2.04%
1 week+3.98%
Current month-9.40%
1 month-13.61%
3 months-16.41%
6 months-37.95%
Current year-38.07%
More quotes
1 week
19.53
Extreme 19.53
21.40
1 month
19.05
Extreme 19.05
24.30
Current year
17.64
Extreme 17.64
33.57
1 year
17.64
Extreme 17.64
40.12
3 years
17.64
Extreme 17.64
50.58
5 years
17.64
Extreme 17.64
50.58
10 years
17.64
Extreme 17.64
50.58
More quotes
Managers TitleAgeSince
Chief Executive Officer 45 13-07-31
Director of Finance/CFO - 23-09-12
Director/Board Member 38 16-08-31
Members of the board TitleAgeSince
Director/Board Member 61 20-08-31
Director/Board Member 60 23-09-11
Chief Executive Officer 45 13-07-31
More insiders
Date Price Change Volume
24-06-14 20.63 -2.04% 568,463
24-06-13 21.06 +1.49% 578,327
24-06-12 20.75 +0.88% 644,337
24-06-11 20.57 +3.68% 705,976
24-06-07 19.84 +2.74% 865,070

End-of-day quote Shanghai S.E., June 13, 2024

More quotes
Nanjing Medlander Medical Technology Co Ltd is a China-based company mainly engaged in the research and development, production, sales and service of related products in the field of pelvic floor and postpartum rehabilitation. The Company's products mainly include pelvic floor and postpartum rehabilitation equipment, consumables and accessories, information products and others, including biostimulation feedback instruments, basin training instruments, basin biostimulation feedback instruments, vaginal electrodes, pelvic maintenance instruments and others. The Company's products are mainly used in obstetrics and gynecology, gynecology, pelvic floor rehabilitation centers, confinement centers, postpartum rehabilitation centers, mother and child centers and other professional institutions in medical institutions.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688273 Stock